 CAMBRIDGE, Mass.--BUSINESS WIRE--Magenta Therapeutics NASDAQ: MGTA, a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced availability of data presentations across its stem cell mobilization and targeted conditioning programs at the European Society for Blood and Marrow Transplantation EBMT 2021 annual meeting, held virtually March 14-17, 2021. The EBMT Annual Meeting is one of the most imp 